IGNITE Network

The Implementing GeNomics In pracTicE (IGNITE) Pragmatic Clinical Trials Network. Dedicated to supporting the implementation of genomics in healthcare.

[IGNITE Network @IGNITEgenomics]

@SaraWattari @cc_pgx Hi there! We are a pragmatic clinical trials network that focuses on implementing genomics in healthcare! We also keep a list of resources for training opportunities. Read more here: https://t.co/6fB0KFKTWm

[IGNITE Network @IGNITEgenomics]

New ADOPT PGx Depression trial results published in JAMA Network Open!
The pragmatic trial evaluated whether genotype-guided SSRI prescribing could improve depression outcomes, helping advance evidence for precision medicine in depression care.
https://t.co/yVGIOwCVTo

[IGNITE Network @IGNITEgenomics]

New GUARDD-US study published in JAMA Network Open!
The pragmatic trial evaluated returning APOL1 genetic risk results to patients with hypertension and their clinicians, examining impacts on blood pressure control and CKD screening in real-world care.
https://t.co/y6cTO3VdnJ

[IGNITE Network @IGNITEgenomics]

New ADOPT-PGx study published in JAMA Network Open, with an invited commentary.
The pragmatic trial evaluated CYP2D6-guided opioid prescribing for postoperative pain and offers key insights into real-world pharmacogenetic implementation.
https://t.co/Lkb9kgpK4z

[IGNITE Network @IGNITEgenomics]

REAL-WORLD IMPACT OF CYP2C19 GENOTYPE-INFORMED ANTIPLATELET THERAPY ON CARDIOVASCULAR OUTCOMES FOLLOWING PERCUTANEOUS CORONARY INTERVENTION. https://t.co/FMrkyxBh7M

[IGNITE Network @IGNITEgenomics]

REAL-WORLD EVALUATION OF CYP2C19 INHIBITOR PHENOCONVERSION ON CLOPIDOGREL CLINICAL EFFECTIVENESS AFTER PERCUTANEOUS CORONARY INTERVENTION https://t.co/pRwTRm1vNa

[IGNITE Network @IGNITEgenomics]

IGNITE is excited to share upcoming research at #AHA25 in New Orleans! Don’t miss the moderated digital poster: CYP2C19-Guided Antiplatelet Therapy Influences Outcomes After PCI in Black Patients. Nov. 10, 1:45 p.m. https://t.co/vgeFpwNjf8

[NASEM Health @NASEM_Health]

Join us on October 28 for a hybrid public workshop to discuss how AI is impacting translational #genomics research and genomics clinical care.
Register here: https://t.co/k1rwQnPj6j
#GenomicsRT

[IGNITE Network @IGNITEgenomics]

The ADVANCE (#AI) Center at @VUMCHealth is hosting its Fall 2025 Symposium “Translating AI into Practice” Oct. 8-9!

RSVP here: https://t.co/JCip6j9Fw1

[ASHG @GeneticsSociety]

🎥First time at #ASHG25? You’re not alone!
Join our upcoming webinar to hear from ASHG volunteers on how to navigate the ASHG 2025 like a pro—from badge pick-up to networking tips.
🎟️ Register now & get your questions answered live!
🔗 https://t.co/3io3G35cuU #ASHG #HumanGenetics

[European Society of Human Genetics (ESHG) @eshgsociety]

A gene therapy may be the first to slow Huntington’s disease. UniQure reports a 75% reduction in symptom progression over 3 years in a small trial. Read more: https://t.co/iOZWOp2C48

[GGMC @GlobalGenMed]

In August, the IHCC hosted a three-day conference with Precision Health Research, Singapore (PRECISE), uniting top experts in #genomics and #healthresearch.

Check out our summary here:
https://t.co/2KFKc8LaaL

A huge thank you to PRECISE for helping make this happen!

[DukePrecisionGenomics @DukeGenomics]

In the first population-based study from Africa, H3Africa KDRN recruited over 8,000 people in Ghana and Nigeria to investigate the role of having one or two copies of the APOL1 variants.
@DukeMedSchool

[GGMC @GlobalGenMed]

🧬 TOMORROW 🧬

There's still time to join us for the next GGMC Educational Webinar Series feat. Dr. Lyndon J. Mitnaul, who will discuss the "Together for Change" initiative.

Live at 9AM EST. Sign up: https://t.co/DHuu0ck0q8

@Regeneron #Genomics #TogetherForChange

[IGNITE Network @IGNITEgenomics]

🚨 Pub alert! 🚨 IGNITE ADOPT PGx investigators explored the impact of genetic testing on opioid treatment for #chronicpain. Learn more about how #pharmacogenomics can enhance pain control and minimize adverse effects! 💊✨ https://t.co/kvDCZZyx2q

[GGMC @GlobalGenMed]

🔷 NEXT WEBINAR!

🔹We're excited to have Dr. Brian Carney speak about Sickle Cell Trait (or #SCT) and the inadequacy and inequality that exists in treatment-->September 27, 2024, 9:00 am EST, 2:00 PM UK

🔹Register HERE: https://t.co/DHuu0ck0q8

#SickeCell #SickleCellTrait

[GGMC @GlobalGenMed]

🌐 We're excited to announce that our 8th International Conference of G2MC will be held in Colombo, Sri Lanka from March 31 to April 3, 2025!

Join us at @ColomboUni! Registration details will be available soon: https://t.co/tz0dFWg5mc

🇱🇰 #GenomicMedicine 🇱🇰

[GGMC @GlobalGenMed]

🔻 We want to thank everyone who attended our latest webinar and especially to Kawmadi Gunawardena for her talk!

The entirety of her webinar is available to view via our Youtube page.

Watch here (and subscribe) 🤳
https://t.co/5edOAXKBxI

#genomics #srilankangenomics

[GGMC @GlobalGenMed]

🔹We're excited to announce our next #webinar will feature Dr. Geoff Ginsburg! (@PersonalizedMed)

🔷His talk, which will go over #AllofUs and their data collection efforts to accelerate research and improve health, will stream March 28th!

Register HERE: https://t.co/DHuu0ck0q8

[IGNITE Network @IGNITEgenomics]

Pub alert! In this @PGSjournal article co-authors Meghna Bhatt, Beth Peshkin, Sadaf Kazi, @schwartm, @NadiaAshai, @SandraSwainMD & @MaxPGx identify oncologists who believe #pharmacogenomic testing can improve cancer care. https://t.co/UEqInS2KQA

[GGMC @GlobalGenMed]

☝️ A REMINDER, Dr. George P. Patrinos will be our next Webinar Speaker!

Be there FEB. 15th, 2024 at 9:00am EST / 2:00pm UTC

REGISTER 👉 https://t.co/DHuu0ck0q8

#personalizedtheraputics